Newsfeeds - Spark Newswire

4 minute read

The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures

Today, 8:57 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)

ALXN

3 minute read

Labcorp Launches Companion Diagnostic For Amgen’s Newly-Approved Lung Cancer Therapy

By Benzinga Newsdesk

Today, 8:57 AM

Labcorp® (NYSE:LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with

AMGN

1 minute read

Amgen Pumps $365M Into New Ohio Facility

By Vandana Singh

Today, 8:57 AM

Amgen Inc (NASDAQ:AMGN) plans to build a $365 million pharmaceutical packaging facility in New Albany that will employ 400 workers. The…

AMGN

6 minute read

14 Biotech Stocks To Watch Over The Next 6 Months

By Shanthi Rexaline

Today, 8:57 AM

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks.

AERI

4 minute read

The Daily Biotech Pulse: Gemini Sinks On Data, Amgen’s Migraine Drug Approved In Japan, Liver Congress Gets Underway

By Shanthi Rexaline

Today, 8:57 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22)

ACET

3 minute read

FDA
News

Amgen Announced Approval Of Aimovig In Japan For The Suppression Of Onset Of Migraine Attacks In Adults

By Charles Gross

Today, 8:57 AM

Amgen (NASDAQ: AMGN) today announced that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for Aimovig® (erenumab) for the suppression of onset of migraine attacks in adults.

AMGN

3 minute read

IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings

By Chris Katje

Today, 8:57 AM

This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.

ABBV

1 minute read

Amgen’s Stomach Cancer Drug Acquired in Five Prime Buyout Extends Patients’ Lives, Mid-Stage Study Shows

By Vandana Singh

Today, 8:57 AM

Amgen Inc (NASDAQ:AMGN) has announced updated results for investigational bemarituzumab combined with chemotherapy from the Phase 2 FIGHT trial in patients…

AMGN

7 minute read

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

By Shanthi Rexaline

Today, 8:57 AM

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.

ADAP

1 minute read

Amgen’s First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer

By Vandana Singh

Today, 8:57 AM

The FDA has given accelerated approval to Amgen Inc’s (NASDAQ:AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras mutation.…

AMGN